Spots Global Cancer Trial Database for Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome
Official Title: A Comparative Clinical Study Evaluating the Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome in Egyptian Women
Study ID: NCT05200793
Conditions
Study Description
Brief Summary: The study aims to compare the efficacy of Empagliflozin or Linagliptin as an alternative to Metformin for treatment of non-diabetic patients with polycystic ovary syndrome (PCOS).
Detailed Description: Patients with polycystic ovary syndrome will be randomized to three arms: * Metformin (standard care) * Empagliflozin or Linagliptin Resolution of the syndrome in addition to normalization of sex hormones, metabolic and inflammatory parameters will be tested
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Alexandria University, Alexandria, , Egypt
Contact Details
Name: Hanan N Abdel Hafez, PhD
Affiliation: Professor of Obstetrics and Gynecology, Faculty of Medicine Mansoura University
Role: STUDY_CHAIR
Name: Ahmed I ElMallah, PhD
Affiliation: Professor of Pharmacology and Therapeutics, Faculty of Pharmacy Alexandria University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
